Conversely, excessive JAK2 activity may impair this process; hepatocyte-specific JAK2 deletion alleviates HFD-induced steatohepatitis and insulin resistance [23], while its overactivation suppresses Akt signaling [24], potentially exacerbating insulin resistance. Here, AKT1 is linked to Insulin resistance.